DILH
WST icon

Dai-ichi Life Holdings’s West Pharmaceutical WST Stock Holding History

Dai-ichi Life Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-24,384
Closed -$1.32M – 578
2015
Q3 		$1.32M Buy
+24,384
New +$1.42M 0.04% 384

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Dai-ichi Life Holdings's WST Position: Q4 2015 in Review

Dai-ichi Life Holdings sold out of West Pharmaceutical (WST) in Q4 2015, closing a stake of 24,384 shares — an estimated $1.32M sold.

Dai-ichi Life Holdings first reported a position in WST in Q3 2015 and held it in 1 quarter. The position peaked at $1.32M in Q3 2015. 249 funds tracked by Wall St. Rank hold WST as of Q4 2015.

  • Dai-ichi Life Holdings reported no remaining West Pharmaceutical position as of Q4 2015 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 24,384 West Pharmaceutical shares in Q4 2015, an estimated $1.32M.
  • Dai-ichi Life Holdings first reported a position in West Pharmaceutical in Q3 2015 and held it in 1 quarter.
  • Dai-ichi Life Holdings's West Pharmaceutical position peaked at $1.32M in Q3 2015.
  • 249 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2015.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2015, filed 10 Feb 2016.